Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAS | RKDA | GOVX | ||
| Company | Phasebio Pharmaceuticals Inc | Arcadia Biosciences Inc | Geovax Labs Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0800 | 2.04 | 1.9800 | ||
| High | 0.0920 | 2.20 | 1.9900 | ||
| Low | 0.0665 | 1.70 | 1.8100 | ||
| Latest | 0.0701 | 2.03 | 1.8700 | ||
| Change | -0.0249 | -0.01 | -0.0600 | ||
| % Change | -26.21% | -0.49% | -3.11% | ||
| Volume | 9,647,400 | 46,600 | 78,700 | ||
| 20-Day Average Volume | 3,930,150 | 24,400 | 145,170 | ||
| Previous Close | 0.0950 | 2.04 | 1.9300 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1610 | 1.87 | 1.7400 | ||
| 20-Day Raw Stochastic | 2.27% | 71.09% | 42.09% | ||
| 20-Day Relative Strength | 20.88 | 48.19 | 35.27 | ||
| Weighted Alpha | -91.26 | -54.74 | -83.90 | ||
| Today's Opinion | 100% Sell | 80% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 80% Sell | 88% Sell | ||
| Last Month's Opinion | 72% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.40% since 10/26/22 | +10.03% since 03/04/26 | +9.36% since 03/04/26 | ||
| Low | 0.0665 on 11/02/22 | 1.70 on 03/11/26 | 1.6100 on 03/05/26 | ||
| High | 0.1440 on 10/27/22 | 2.23 on 03/09/26 | 1.9900 on 03/11/26 | ||
| 1-Month | |||||
| %Chg | -60.17% since 09/30/22 | +18.02% since 02/11/26 | -26.67% since 02/11/26 | ||
| Low | 0.0665 on 11/02/22 | 1.54 on 02/17/26 | 1.2600 on 02/19/26 | ||
| High | 0.2250 on 10/14/22 | 2.23 on 03/09/26 | 2.6200 on 02/12/26 | ||
| 3-Month | |||||
| %Chg | -93.85% since 08/02/22 | -45.14% since 12/11/25 | -80.71% since 12/11/25 | ||
| Low | 0.0665 on 11/02/22 | 1.54 on 02/17/26 | 1.2600 on 02/19/26 | ||
| High | 1.3800 on 08/09/22 | 3.80 on 12/17/25 | 9.8000 on 12/12/25 | ||
| 6-Month | |||||
| %Chg | -94.35% since 05/02/22 | -41.67% since 09/11/25 | -89.56% since 09/11/25 | ||
| Low | 0.0665 on 11/02/22 | 1.54 on 02/17/26 | 1.2600 on 02/19/26 | ||
| High | 1.3800 on 08/09/22 | 6.71 on 10/08/25 | 18.0000 on 09/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,495 | 3,512 | 3,406 | ||
| Shares Outstanding, K | 49,858 | 1,730 | 1,822 | ||
| Annual Sales | 10,830,000 | 5,050,000 | 3,950,000 | ||
| Annual Net Income | -131,070,000 | -7,040,000 | -24,990,000 | ||
| Last Quarter Sales | 210,000 | 1,300,000 | 850,000 | ||
| Last Quarter Net Income | -16,670,000 | 860,000 | -5,370,000 | ||
| 60-Month Beta | 2.57 | 0.57 | 3.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 08/12/22 | 0.62 on 11/07/25 | -0.31 on 11/13/25 | ||
| Latest Earnings Date | 11/09/22 | 03/19/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||